Is paroxetine an effective treatment for hot flashes?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 5, 2006, Pages 250-251

  Casper, R F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; PAROXETINE; PLACEBO;

ADULT; BREAST CANCER; CANCER SURVIVOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOT FLUSH; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 33646566513     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0158     Document Type: Note

References (5)

1. Simpkins JW et al. (1983) Similarities between morphine withdrawal in the rat and the menopausal hot flush. Life Sci 32: 1957-1966
2. Casper RF et al. (1987) Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 47: 341-344
3. Akaoka H and Aston-Jones G (1993) Indirect seroternergic agonists attenuate neuronal opiate withdrawal. Neuroscience 54: 561-565
4. Rafieian-Kopaei M et al. (1995) Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. Eur J Pharmacol 275: 185-189
5. Jin Y et al. (2005) CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 97: 30-39